scholarly journals Cardiac remodeling and diastolic dysfunction in DahlS.Z-Leprfa/Leprfa rats: a new animal model of metabolic syndrome

2011 ◽  
Vol 35 (2) ◽  
pp. 186-193 ◽  
Author(s):  
Tamayo Murase ◽  
Takuya Hattori ◽  
Masafumi Ohtake ◽  
Mayuna Abe ◽  
Yui Amakusa ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Animal Model ◽  
Diastolic Dysfunction ◽  
Cardiac Remodeling

Cardiac Remodeling and Diastolic Dysfunction in DahlS.Z-Leprfa/Leprfa Rats as a New Rat Model of Metabolic Syndrome

2010 ◽  
Vol 16 (9) ◽  
pp. S147
Author(s):  
Tamayo Murase ◽  
Takuya Hattori ◽  
Miwa Takatsu ◽  
Mayuna Abe ◽  
Yui Amakusa ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Diastolic Dysfunction ◽  
Rat Model ◽  
Cardiac Remodeling

scholarly journals Calorie Restriction Attenuates Cardiac Remodeling and Diastolic Dysfunction in a Rat Model of Metabolic Syndrome

Hypertension ◽  
2013 ◽  
Vol 62 (5) ◽  
pp. 957-965 ◽  
Author(s):  
Miwa Takatsu ◽  
Chieko Nakashima ◽  
Keiji Takahashi ◽  
Tamayo Murase ◽  
Takuya Hattori ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Diastolic Dysfunction ◽  
Calorie Restriction ◽  
Rat Model ◽  
Cardiac Remodeling

Saskatoon berry supplementation prevents cardiac remodeling without improving renal disease in an animal model of reno‐cardiac syndrome

2021 ◽  
Vol 45 (10) ◽  
Author(s):  
Pema Raj ◽  
Xavier L. Louis ◽  
Liping Yu ◽  
Yaw L. Siow ◽  
Miyoung Suh ◽  
...  
Keyword(s):  
Animal Model ◽  
Renal Disease ◽  
Cardiac Remodeling ◽  
Cardiac Syndrome

scholarly journals Kefir reduces insulin resistance and inflammatory cytokine expression in an animal model of metabolic syndrome

2016 ◽  
Vol 7 (8) ◽  
pp. 3390-3401 ◽  
Author(s):  
Damiana D. Rosa ◽  
Łukasz M. Grześkowiak ◽  
Célia L. L. F. Ferreira ◽  
Ana Carolina M. Fonseca ◽  
Sandra A. Reis ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Metabolic Syndrome ◽  
Animal Model ◽  
Inflammatory Cytokine ◽  
Fasting Glucose ◽  
Cytokine Expression ◽  
Fasting Insulin ◽  
Insulin Levels ◽  
Reduce Insulin Resistance

Kefir supplementation in rats with induced metabolic syndrome was able to lower fasting glucose, fasting insulin levels, and reduce insulin resistance.

scholarly journals Increased Lipid Synthesis and Decreased β-Oxidation in the Liver of SHR/NDmcr-cp (cp/cp) Rats, an Animal Model of Metabolic Syndrome

Lipids ◽  
2013 ◽  
Vol 48 (11) ◽  
pp. 1115-1134 ◽  
Author(s):  
Shizuyo Tanaka ◽  
Tohru Yamazaki ◽  
Satoshi Asano ◽  
Atsushi Mitsumoto ◽  
Daisuke Kobayashi ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Animal Model ◽  
Lipid Synthesis

scholarly journals Prevalence of Diastolic Dysfunction in Non Diabetic Patients of Metabolic Syndrome

2021 ◽  
Author(s):  
Kaushiki Kirty ◽  
Prabha Adhikari
Keyword(s):  
Metabolic Syndrome ◽  
Risk Factor ◽  
Diastolic Dysfunction ◽  
Strong Correlation ◽  
Past History ◽  
Diabetic Patients ◽  
Short Term ◽  
The Metabolic Syndrome ◽  
History Of

Abstract Background :The purpose of the present study was to study the prevalence of metabolic syndrome in non diabetic patients of metabolic syndrome Materials and Methods: 100 patients of non diabetic metabolic syndrome were screened using 2-D Echocardiogram.Results: 34% of non diabetic patients of metabolic syndrome had diastolic dysfunction, with no association found between the components of metabolic syndrome and diastolic dysfunction. There was a strong correlation between a past history of hypertension and dyslipidemia with diastolic dysfunction.Conclusion: Our findings suggest that long standing metabolic syndrome is a risk factor for diastolic dysfunction, rather than short term elevation of the metabolic syndrome parameters. Also it is likely that Diabetes and Prediabetes itself is responsible for most of the diastolic dysfunction that is seen in metabolic syndrome

scholarly journals Non-alcoholic fatty liver disease and left ventricular diastolic dysfunction in patients with metabolic syndrome

2020 ◽  
Vol 183 (11) ◽  
pp. 25-33
Author(s):  
S. N. Jadhav ◽  
V. G. Radchenko
Keyword(s):  
Metabolic Syndrome ◽  
Liver Disease ◽  
Diastolic Dysfunction ◽  
Liver Damage ◽  
Fatty Liver Disease ◽  
Left Ventricular Diastolic Dysfunction ◽  
Left Ventricular ◽  
Alcoholic Fatty Liver ◽  
Ventricular Diastolic Dysfunction ◽  
Alcoholic Fatty Liver Disease

The purpose of the study was to determine the frequency and nature of manifestations of left ventricular diastolic dysfunction in patients with non-alcoholic fatty liver disease with the background of metabolic syndrome (MS).Characteristics of patients and research methods: To solve this problem, 227 patients with MS (130 men and 97 women) were examined. The study was conducted in two phases. At the first stage, all patients with MS are divided into two groups: patients with NAFLD — 205 people and 22 — without liver damage. At the next stage, a group of NAFLD patients with left ventricular DD (n=136) (66.34%) (the main group) and patients with no DD (n=69) (33.66%) (the comparison group) were identified.Results of the study: the results of diagnostics, clinical and laboratory manifestations of left ventricular diastolic dysfunction in 136 patients with NAFLD on the background of metabolic syndrome are Presented. Significant factors of development and progression of diastolic dysfunction were identified, which include increased body weight and adipose tissue, insulin resistance, dyslipidemia, hyperuricemia, activity and stage of liver damage. According to the data of structural and functional changes in the myocardium, the role of diastolic dysfunction in the development of chronic heart failure in patients with NAFLD with manifestations of metabolic syndrome has been established.Conclusion: it was Found that the development of left ventricular diastolic dysfunction in patients with NAFLD is due to the morphofunctional state of the liver.

Sign in / Sign up

Export Citation Format

Share Document